Skip to main content
. 2018 Jul 17;9(55):30568–30586. doi: 10.18632/oncotarget.25736

Table 3. Benchmark etoposide cytotoxicity in EWS cell lines.

Cell line Efficacy (EC50) µM Sensitivity24 hrs
% dead cells per nM morpholino (r2)
Fraction dead cells at 24 hours (FA24 hs)
HEK293 (control) 0.73 0.068 (0.895) 0.16 ± 0.01
TC-32 0.64 0.078 (0.900) 0.26 ± 0.05*
CHLA-9 0.43 0.117 (0.889) 0.32 ± 0.03*
CHLA-10 0.32 0.156 (0.915) 0.41 ± 0.05*

Fraction Dead Cells at 24 hours (FA24 hrs) represents the activity of the agent and is calculated for individual cell lines using the fraction of cells lost among 5 biological replicates at the most potent concentration of etoposide, corrected to the average fraction of cells lost using a DMSO vehicle control only; All replicates were measured on the same 96-well tray and were seeded with an identical number of starting cells, 24 hours prior to etoposide treatment (see methods).

*p < 0.05, based on paired student t-test comparing mean corrected activity (FA24 hrs) at 24 hours.